The Chase Group is pleased to announce the successful completion of the Vice President, Global Head of Data Sciences search at Genmab. A scientist with a pragmatic approach to innovation in healthcare, the successful candidate is regarded as a leader with the ability to think conceptually, making him a valuable member of the team at Genmab. The new Vice President joined the Genmab team earlier this month and is already engaged in designing, developing, and implementing the informatics and computational biology arm of the Translational Research Department.The Chase Group proudly connects life-changing companies with executives and would like to congratulate Genmab on securing such a high caliber talent for their team. We value our continued partnership, helping Genmab in their mission to create and develop differentiated antibody therapeutics for the treatment of cancer.
The Chase Group Secures the Vice President, Global Head of Data Sciences for Genmab
The Chase Group is pleased to announce the successful completion of the Vice President, Global Head of Data Sciences search at Genmab. A scientist with a pragmatic approach to innovation in healthcare, the successful candidate is regarded as a leader with the ability to think conceptually, making him a valuable member of the team at Genmab. The new Vice President joined the Genmab team earlier this month and is already engaged in designing, developing, and implementing the informatics and computational biology arm of the Translational Research Department.The Chase Group proudly connects life-changing companies with executives and would like to congratulate Genmab on securing such a high caliber talent for their team. We value our continued partnership, helping Genmab in their mission to create and develop differentiated antibody therapeutics for the treatment of cancer.
The Chase Group Makes Another Successful Placement at Eli Lilly
The Chase Group is pleased to continue our partnership with Eli Lilly in the successful placement of a new Senior Medical Advisor, Medical Affairs on…
Aeglea BioTherapeutics Builds Rare Disease Clinical Development Team Through Partnership with The Chase Group, Inc.
Through our ongoing partnership, Aeglea Biotherapeutics has secured a Vice President, Clinical Development, Rare Disease. The new Vice President will play a crucial role in…-
Eli Lilly Welcomes New Vice President, Immuno-Oncology Global & US Medical Affairs
The Chase Group is pleased to announce the placement of the Vice President, Immuno-Oncology Global & US Medical Affairs for Eli Lilly. The successful candidate… 
The Chase Group Places VP of Clinical Development and Pharmacovigilance at Marinus Pharmaceuticals
The Chase Group is pleased to continue partnership with Marinus in building their leadership team with the recent placement of the Vice President of Clinical…-
The Chase Group Secures the Vice President, US and Global Medical Affairs for Eli Lilly
The Chase Group is pleased to announce the successful completion of the Vice President, US and Global Medical Affairs at Eli Lilly. The new Vice… 
Ionis Pharmaceuticals Secures Associate Director, Investor Relations
The Chase Group is pleased to announce our latest placement for Ionis Pharmaceuticals. Due to exciting organizational growth, Ionis welcomes a new Associate Director, Investor…